BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/7/2019 7:09:17 AM | Browse: 678 | Download: 1048
 |
Received |
|
2019-04-28 00:36 |
|
Peer-Review Started |
|
2019-04-28 01:24 |
|
To Make the First Decision |
|
2019-05-27 00:31 |
|
Return for Revision |
|
2019-05-30 01:15 |
|
Revised |
|
2019-06-07 03:49 |
|
Second Decision |
|
2019-06-20 09:17 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-06-26 04:39 |
|
Articles in Press |
|
2019-06-26 04:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-07-09 16:20 |
|
Typeset the Manuscript |
|
2019-08-06 02:33 |
|
Publish the Manuscript Online |
|
2019-08-07 07:09 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Wang, Ying Xie, Fei Chen, Xu Liu, Li-Li Zhong, Hai-Qiang Wang and Qing-Chang Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qing-Chang Li, PhD, Doctor, College of Basic Medical Sciences, China medical University and Department of Pathology, the First Affiliated Hospital of China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110001, Liaoning Province, China. sci18846185819@126.com |
| Key Words |
LncRNA; Maternally expressed gene 3; Biomarker; Colorectal cancer; Adenosine deaminase acting on RNA 1; |
| Core Tip |
Long non-coding RNAs (LncRNA) maternally expressed gene 3 (MEG3) is down-regulated in tissue, cell lines and serum. colorectal cancer (CRC) patients with down-regulated serum MEG3 level were more probably had larger tumor size, and advanced clinical stage. LncRNA MEG3 functions as a diagnosis and prognosis in CRC. LncRNA MEG3 promotes cell proliferation and induced apoptosis in CRC. Adenosine deaminase acting on RNA 1 may be the target regulated by lncRNA MEG3 in CRC. |
| Publish Date |
2019-08-07 07:09 |
| Citation |
Wang W, Xie Y, Chen F, Liu X, Zhong LL, Wang HQ, Li QC. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World J Gastroenterol 2019;25(29): 3972-3984 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i29/3972.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i29.3972 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
